Pre-Clinical Results for EB612: First-in-Class Oral Long-Acting PTH(1-34) Analog as Hormone Replacement Tablet for Patients with Hypoparathyroidism

Jun 15, 2026 from 1:00 PM to 2:30 PM EDT

Supporting Materials